
You must be at least 21 years old to access this website.
Our Products are for research and/or investigative purposes and are not suitable for direct human consumption or consumers, nor are they intended for clinical or therapeutic use. The statements and products listed on this website are not intended to diagnose, treat, cure, or prevent any disease. As such, they have not been evaluated or approved by the Federal Food and Drug Administration (the “FDA”). We are not a compounding pharmacy or outsourcing facility as defined under either Section 503A and 503B of the Federal Food, Drug, and Cosmetic Act.
Your cart is empty
Add compounds to get started
Research Comparison
MOTS-c and NAD+ are both central to metabolic research but differ fundamentally. MOTS-c is a mitochondrial-derived signaling peptide studied for AMPK activation, while NAD+ is a coenzyme studied for mitochondrial function, sirtuin activation, and DNA repair.
| Attribute | MOTS-c | NAD+ |
|---|---|---|
| Type | Signaling peptide | Coenzyme / dinucleotide |
| Key pathway | AMPK activation | Sirtuin activation, PARP-1 |
| Research focus | Metabolic regulation, exercise mimetic | Mitochondrial function, aging |
They intersect in mitochondrial metabolism but act differently — MOTS-c is a peptide that activates AMPK signaling, whereas NAD+ is a coenzyme central to sirtuin activity and DNA repair.